EcoDrugPlus

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSCGOG00000013883
Gene Symbol: TRPA1
3 Cross references
201 Possible Orthologues:

Transthyretin

Ensembl ID : ENSCGOG00000011190
Gene Symbol: TTR
3 Cross references
180 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSCGOG00000005123
Gene Symbol: TPH1
3 Cross references
202 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSCGOG00000018472
Gene Symbol: TUBA4A
3 Cross references
158 Possible Orthologues:

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSCGOG00000010907
Gene Symbol: LOC115028811
2 Cross references
179 Possible Orthologues:

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSCGOG00000017339
Gene Symbol: LOC115020801
2 Cross references
144 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSCGOG00000013817
Gene Symbol: LOC115015364
2 Cross references
245 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSCGOG00000023246
Gene Symbol: LOC115022763
3 Cross references
301 Possible Orthologues:

Tubulin Beta-6 Chain-Like

Ensembl ID : ENSCGOG00000013226
Gene Symbol: LOC115008125
2 Cross references
184 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSCGOG00000006974
Gene Symbol: TP53
3 Cross references
231 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSCGOG00000010328
Gene Symbol: TYR
3 Cross references
196 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSCGOG00000016888
Gene Symbol: TYR
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).